What is Monopar Therapeutics's total revenue?

Monopar Therapeutics (MNPR) reported total revenue of $0 in Q1 2026.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Monopar Therapeutics MNPR Total Revenue

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Eli LillyLLY

$19.8B+55.5%

Bausch Health CompaniesBHC

$2.52B+11.7%

Ultragenyx PharmaceuticalRARE

$136M-2.2%

Prime MedicinePRME

$838K-61.6%

Wave Life SciencesWVE

$38.25M+317%

Other financials

Income statement

See full

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's total revenue?: Monopar Therapeutics (MNPR) reported total revenue of $0 in Q1 2026.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.